1. Home
  2. TACO vs CTKB Comparison

TACO vs CTKB Comparison

Compare TACO & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TACO
  • CTKB
  • Stock Information
  • Founded
  • TACO 2024
  • CTKB 1990
  • Country
  • TACO United States
  • CTKB United States
  • Employees
  • TACO N/A
  • CTKB N/A
  • Industry
  • TACO Blank Checks
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • TACO Finance
  • CTKB Health Care
  • Exchange
  • TACO Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • TACO 389.8M
  • CTKB 430.6M
  • IPO Year
  • TACO 2025
  • CTKB 2021
  • Fundamental
  • Price
  • TACO $10.49
  • CTKB $3.88
  • Analyst Decision
  • TACO
  • CTKB Hold
  • Analyst Count
  • TACO 0
  • CTKB 4
  • Target Price
  • TACO N/A
  • CTKB $6.00
  • AVG Volume (30 Days)
  • TACO 22.2K
  • CTKB 930.3K
  • Earning Date
  • TACO 01-01-0001
  • CTKB 08-06-2025
  • Dividend Yield
  • TACO N/A
  • CTKB N/A
  • EPS Growth
  • TACO N/A
  • CTKB N/A
  • EPS
  • TACO N/A
  • CTKB N/A
  • Revenue
  • TACO N/A
  • CTKB $197,050,000.00
  • Revenue This Year
  • TACO N/A
  • CTKB $0.74
  • Revenue Next Year
  • TACO N/A
  • CTKB $7.85
  • P/E Ratio
  • TACO N/A
  • CTKB N/A
  • Revenue Growth
  • TACO N/A
  • CTKB N/A
  • 52 Week Low
  • TACO $10.10
  • CTKB $2.37
  • 52 Week High
  • TACO $11.26
  • CTKB $7.63
  • Technical
  • Relative Strength Index (RSI)
  • TACO N/A
  • CTKB 64.00
  • Support Level
  • TACO N/A
  • CTKB $3.44
  • Resistance Level
  • TACO N/A
  • CTKB $3.44
  • Average True Range (ATR)
  • TACO 0.00
  • CTKB 0.19
  • MACD
  • TACO 0.00
  • CTKB 0.04
  • Stochastic Oscillator
  • TACO 0.00
  • CTKB 93.49

About TACO Berto Acquisition Corp. Ordinary Shares

Berto Acquisition Corp is a blank check company.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: